Neurological events during long-term mechanical circulatory support for heart failure: The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience

Circulation

Volumn 109, Issue 20, 2004, Pages 2423-2427

  Lazar, Ronald M ^a,g   Shapiro, Peter A ^a   Jaski, Brian E ^b   Parides, Michael K ^a   Bourge, Robert C ^c   Watson, John T ^d   Damme, Laura ^e   Dembitsky, Walter ^b   Hosenpud, Jeffrey D ^h   Gupta, Lopa ^a   Tierney, Anita ^a   Kraus, Tonya ^f   Naka, Yoshifumi ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b SHARP MEMORIAL HOSPITAL   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e THORATEC CORPORATION   (United States)

^f INOVA FAIRFAX HOSPITAL   (United States)

^g NEUROLOGICAL INSTITUTE   (United States)

^h NONE

Author keywords

Heart failure; Heart assist device; Stroke

Indexed keywords

AGE; ARTICLE; ASSISTED CIRCULATION; BRAIN FUNCTION; COGNITION; CONGESTIVE HEART FAILURE; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; METABOLIC ENCEPHALOPATHY; NEUROLOGIC DISEASE; NEUROPROTECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; STROKE; SURVIVAL; TRANSIENT ISCHEMIC ATTACK;

BRAIN DISEASES; CEREBROVASCULAR ACCIDENT; DISEASE-FREE SURVIVAL; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; ISCHEMIC ATTACK, TRANSIENT;

EID: 2542474026     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000129414.95137.CD     Document Type: Article

References (32)

1. 2001 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2000.
2. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation. 2002;106:836-841.
3. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
4. Holman WL, Bourge RC, Spruell RD, et al. Ventricular assist devices as a bridge to cardiac transplantation: a prelude to destination therapy. Ann Surg. 1997;225:695-704; discussion 705-706.
5. Ashton RC Jr, Goldstein DJ, Rose EA, et al. Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant. 1996;15:1151-1157.
6. Arabia FA, Smith RG, Rose DS, et al. Success rates of long-term circulatory assist devices used currently for bridge to heart transplantation. ASAIO J. 1996;42:M542-M546.
7. Deng MC, Wilhelm M, Weyand M, et al. Long-term left ventricular assist device support: a novel pump rate challenge exercise protocol to monitor native left ventricular function. J Heart Lung Transplant. 1997;16:629-635.
8. Despotis GJ, Levine V, Joist H, et al. Multiple episodes of thrombosis with biventricular support devices with inadequate anticoagulation and evidence of accelerated intravascular coagulation. J Thorac Cardiovasc Surg. 1997;113:419-422.
9. Slater JP, Rose EA, Levin HR, et al. Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg 1996;62:1321-1327; discussion 1328.
10. Spanier T, Oz M, Levin H, et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg. 1996;112:1090-1097.
11. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991;325:1468-1475.
12. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
13. Rose EA, Moskowitz AJ, Packer M, et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg. 1999;67:723-730.
14. Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989;46:660-662.
15. Elkind MS, Cheng J, Boden-Albala B, et al. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke. 2002;33:31-37.
16. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
17. Quaini E, Pavie A, Chieco S, et al. The Concerted Action "Heart" European registry on clinical application of mechanical circulatory support systems: bridge to transplant. The Registry Scientific Committee. Eur J Cardiothorac Surg. 1997;11:182-188.
18. Schmid C, Weyand M, Nabavi DG, et al. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg. 1998;65:1703-1710.
19. Koul B, Solem JO, Steen S, et al. HeartMate left ventricular assist device as bridge to heart transplantation. Ann Thorac Surg. 1998;65:1625-1630.
20. McCarthy PM, Smedira NO, Vargo RL, et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg. 1998;115:904-912.
21. Reilly MP, Wiegers SE, Cucchiara AJ, et al. Frequency, risk factors, and clinical outcomes of left ventricular assist device-associated ventricular thrombus. Am J Cardiol 2000;86:1156-1159, A10.
22. Thomas CE, Jichici D, Petrucci R, et al. Neurologic complications of the Novacor left ventricular assist device. Ann Thorac Surg. 2001;72:1311-1315.
23. Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA. 1983;250:2942-2946.
24. Pullicino PM, Halperin JL, Thompson JL. Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology. 2000;54:288-294.
25. Sacco RL, Shi T, Zamanillo MC, et al. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626-634.
26. Prencipe M, Culasso F, Rasura M, et al. Long-term prognosis after a minor stroke: 10-year mortality and major stroke recurrence rates in a hospital-based cohort. Stroke. 1998;29:126-132.
27. Spanier TB, Chen JM, Oz MC, et al. Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. J Thorac Cardiovasc Surg. 1999;118:404-413.
28. Mohr JP. Acute clinical trials: an expression of concern. Cerebrovasc Dis. 1999;9(suppl 3):45-50.
29. Roman GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 2002;203-204:7-10.
30. Pullicino PM, Hart J. Cognitive impairment in congestive heart failure? Embolism vs hypoperfusion. Neurology. 2001;57:1945-1946.
31. Zuccala G, Onder G, Pedone C, et al. Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicentre survey. On behalf of the GIFA (SIGG-ONLUS) Investigators. J Neurol Neurosurg Psychiatry, 2001;70:109-112.
32. International SoHLT. Heart/Lung Registries. Available at: http://www.ishlt.org/registries/. Accessed April 22, 2004.